|
1
|
Wu J and Hong J: Highlights of bronchial
asthma in children guideline (2016 edition) for its diagnosis and
treatment. World Clinic Drugs. 39:512–517. 2018.(In Chinese).
|
|
2
|
Masoli M, Fabian D, Holt S and Beasley R:
Global Initiative for Asthma (GINA) Program. The global burden of
asthma: Executive summary of the GINA Dissemination Committee
report. Allergy. 59:469–478. 2004.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Alvarez-Alvarez I, Niu H, Guillen-Grima F
and Aguinaga-Ontoso Ι: Meta-analysis of prevalence of wheezing and
recurrent wheezing in infants. Allergol Immunopathol (Madr).
46:210–217. 2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Liu SJ, Wang TT, Cao SY, Tan YQ and Chen
LZ: A Meta analysis of risk factors for asthma in Chinese children.
Zhongguo Dang Dai Er Ke Za Zhi. 20:218–223. 2018.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
5
|
Østergaard MS, Nantanda R, Tumwine JK and
Aabenhus R: Childhood asthma in low income countries: An invisible
killer? Prim Care Respir J. 21:214–219. 2012.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Lin JT, Wang WQ, Zhou X, Yin KS, Liu CT,
Wang CZ, Huang M, Chen P, Yuan YD, Cai SX, et al: Trends of asthma
control, disease management and perception in China. Zhonghua Jie
He He Hu Xi Za Zhi. 41:191–195. 2018.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
7
|
Hsieh KH: Evaluation of efficacy of
traditional Chinese medicines in the treatment of childhood
bronchial asthma: Clinical trial, immunological tests and animal
study. Taiwan Asthma Study Group. Pediatr Allergy Immunol.
7:130–140. 1996.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Wang R and Lin J: Analysis of the
mechanism of Zhichuanling oral liquid in treating bronchial asthma
based on network pharmacology. Evid Based Complement Alternat Med.
2020(1875980)2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Wang L, Zheng X, Hui Y, Wang B, Yang Y,
Feng X, Zhang T, Ma L and Zhang X: Adjuvant treatment with
Xiaoqinglong formula for bronchial asthma: Protocol of systematic
review and meta-analysis. Medicine (Baltimore).
98(e17053)2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Su YH, Yu XY, Geng LM, Su KG and Guo YY:
Oral administration versus iontophoresis of Sang-Su decoction (a
formula for dispersing lung to calm panting and resolve phlegm and
for dredging collateral) in the treatment of acute bronchial
asthma: A comparative study on their efficacy and impacts on the
prognosis. Int J Clin Exp Med. 11:1305–1311. 2018.
|
|
11
|
Jin X, Wang D, Xie J, Zhang L and Liu Q:
Effect of Ginkgo Lactone on cholinergic neurotransmitters,
oxidative stress and inflammation in AD model rats induced by
Aβ1-40. J Chin Med Mater. 11:2693–2696. 2019.(In
Chinese).
|
|
12
|
Thorpe LB, Goldie M and Dolan S: Central
and local administration of Gingko biloba extract EGb
761® inhibits thermal hyperalgesia and inflammation in
the rat carrageenan model. Anesth Analg. 112:1226–1231.
2011.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Li XH, Tu XY, Zhang DX, Xu JF, Wang WY,
Zhang Y and Du YM: Effects of wuwei dilong decoction on
inflammatory cells and cytokines in asthma model guinea pigs. J
Tradit Chin Med. 29:220–223. 2009.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Wu WB, Zhu C and Luo C: Research on the
protective effect of alkaloids Pinelliaf Rhizoma on
inflammatory injury of lung epithelial cells. J Inner Mong Agric
Univ. 39:1–8. 2018.
|
|
15
|
Su XD, Jang HJ, Li HX, Kim YH and Yang SY:
Identification of potential inflammatory inhibitors from Aster
tataricus. Bioorg Chem. 92:1–9. 2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Doganci A, Sauer K, Karwot R and Finotto
S: Pathological role of IL-6 in the experimental allergic bronchial
asthma in mice. Clin Rev Allergy Immunol. 28:257–270.
2005.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Martinez-Nunez RT, Bondanese VP, Louafi F,
Francisco-Garcia AS, Rupani H, Bedke N, Holgate S, Howarth PH,
Davies DE and Sanchez-Elsner T: A microRNA network dysregulated in
asthma controls IL-6 production in bronchial epithelial cells. PLoS
One. 9(e111659)2014.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Liu Z, Gan L, Zhou Z, Jin W and Sun C:
SOCS3 promotes inflammation and apoptosis via inhibiting JAK2/STAT3
signaling pathway in 3T3-L1 adipocyte. Immunobiology. 220:947–953.
2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Imada K and Leonard WJ: The Jak-STAT
pathway. Mol Immunol. 37:1–11. 2000.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Huang N, Liu K, Liu J, Gao X, Zeng Z,
Zhang Y and Chen J: Interleukin-37 alleviates airway inflammation
and remodeling in asthma via inhibiting the activation of NF-κB and
STAT3 signalings. Int Immunopharmacol. 55:198–204. 2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Simeone-Penney MC, Severgnini M, Tu P,
Homer RJ, Mariani TJ, Cohn L and Simon AR: Airway epithelial STAT3
is required for allergic inflammation in a murine model of asthma.
J Immunol. 178:6191–6199. 2007.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Simon AR, Takahashi S, Severgnini M,
Fanburg BL and Cochran BH: Role of the JAK-STAT pathway in
PDGF-stimulated proliferation of human airway smooth muscle cells.
Am J Physiol Lung Cell Mol Physiol. 282:L1296–L1304.
2002.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Yan YR, Luo Y, Zhong M and Shao L:
miR-216a inhibits proliferation and promotes apoptosis of human
airway smooth muscle cells by targeting JAK2. J Asthma. 56:938–946.
2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Shi J, Li J, Yang S, Hu X, Chen J, Feng J,
Shi T, He Y, Mei Z, He W, et al: LncRNA SNHG3 is activated by E2F1
and promotes proliferation and migration of non-small-cell lung
cancer cells through activating TGF-β pathway and IL-6/JAK2/STAT3
pathway. J Cell Physiol. 235:2891–2900. 2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Tang Y: Lipid cholesterol mediates the
mechanism of arterial thrombosis by regulating the proliferation
and activation of peripheral blood cells (unpublished PhD thesis).
Jilin University, 2020.
|
|
26
|
Papi A, Brightling C, Pedersen SE and
Reddel HK: Asthma. Lancet. 391:783–800. 2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Brannan JD: Bronchial hyperresponsiveness
in the assessment of asthma control: Airway hyperresponsiveness in
asthma: its measurement and clinical significance. Chest. 1138
(Suppl 2):11S–17S. 2010.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Sarnes E, Crofford L, Watson M, Dennis G,
Kan H and Bass D: Incidence and US costs of
corticosteroid-associated adverse events: A systematic literature
review. Clin Ther. 33:1413–1432. 2011.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Papanicolaou DA, Wilder RL, Manolagas SC
and Chrousos GP: The pathophysiologic roles of interleukin-6 in
human disease. Ann Intern Med. 128:127–137. 1998.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Dimitrova D, Youroukova V,
Ivanova-Todorova E, Tumangelova-Yuzeir K and Velikova T: Serum
levels of IL-5, IL-6, IL-8, IL-13 and IL-17A in pre-defined groups
of adult patients with moderate and severe bronchial asthma. Respir
Med. 154:144–154. 2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Kado S, Nagase T and Nagata N: Circulating
levels of interleukin-6, its soluble receptor and
interleukin-6/interleukin-6 receptor complexes in patients with
type 2 diabetes mellitus. Acta Diabetol. 36:67–72. 1999.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Kuhn C III, Homer RJ, Zhu Z, Ward N,
Flavell RA, Geba GP and Elias JA: Airway hyperresponsiveness and
airway obstruction in transgenic mice. Am J Respir Cell Mol Biol.
22:289–295. 2000.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Gavino AC, Nahmod K, Bharadwaj U,
Makedonas G and Tweardy DJ: STAT3 inhibition prevents lung
inflammation, remodeling, and accumulation of Th2 and Th17 cells in
a murine asthma model. Allergy. 71:1684–1692. 2016.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Lv J, Sun B, Mai Z, Jiang M and Du J:
STAT3 potentiates the ability of airway smooth muscle cells to
promote angiogenesis by regulating VEGF signalling. Exp Physiol.
102:598–606. 2017.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Dickason RR, English JD and Huston DP:
Engineering of a functional interleukin-5 monomer: A paradigm for
redesigning helical bundle cytokines with therapeutic potential in
allergy and asthma. J Mol Med (Berl). 74:535–546. 1996.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Gong JH, Shin D, Han SY, Kim JL and Kang
YH: Kaempferol suppresses eosionphil infiltration and airway
inflammation in airway epithelial cells and in mice with allergic
asthma. J Nutr. 142:47–56. 2012.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Nakano T, Inoue H, Fukuyama S, Matsumoto
K, Matsumura M, Tsuda M, Matsumoto T, Aizawa H and Nakanishi Y:
Niflumic acid suppresses interleukin-13-induced asthma phenotypes.
Am J Respir Crit Care Med. 173:1216–1221. 2006.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Pitman H, Innes BA, Robson SC, Bulmer JN
and Lash GE: Altered expression of interleukin-6, interleukin-8 and
their receptors in decidua of women with sporadic miscarriage. Hum
Reprod. 28:2075–2086. 2013.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Liu F, Yu J, Bai L, Xue Z and Zhang X:
Pingchuan formula improves asthma via restoration of the Th17/Treg
balance in a mouse model. BMC Complement Altern Med.
15(234)2015.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Pan LY, Han YQ, Wang YZ, Chen QQ, Wu Y and
Sun Y: Mechanism of Yanghe Pingchuan granules treatment for airway
remodeling in asthma. Drug Des Devel Ther. 12:1941–1951.
2018.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Wang XH, Yang MX and Yu WT: Effect of
Wenyang Yiqi Pingchuan recipe on pathomorphology of lung and its
regulation on lung tissue contents of nitric oxide and endothelin-1
in rats with bronchial asthma. Zhongguo Zhong Xi Yi Jie He Za Zhi.
29:435–438. 2009.PubMed/NCBI(In Chinese).
|
